SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER) (Omeros) today announced that it has commenced concurrent underwritten public offerings of $125,000,000 of shares of its common stock (the Shares) and $200,000,000 aggregate principal amount of convertible senior notes due 2026 (the 2026 Convertible Notes). In addition, Omeros has granted to the underwriters of the offering of Shares (the Equity Offering) a 30-day option to purchase up to an additional $18,750,000 of Shares and to the u…

Click here to view the original article.